Default company panoramic image

AQCI, Inc.

AQCI product eliminates complex manual Quality Control procedures for the manufacturers of radioactive diagnostic imaging tracers for PET.

  • Stage Concept Only
  • Industry Medical Devices and Equipment
  • Location Los Angeles, CA, USA
  • Currency USD

Company Summary

Our customers are Nuclear Pharmacies who are the commercial suppliers of short-lived radioactive imaging tracers for Positron Emission Tomography (PET), a diagnostic medical imaging modality. By switching from manual Quality Control procedures to AQCI they will realize the following benefits: -(a) immediate operating cost savings (up to $200K/year), (b) elimination of 60% of FDA violations, (c) 4X reduction of personnel radiation exposure.


  • Default avatar
    Arkadij Elizarov

    Dr. Elizarov has a track record of ground-breaking innovation in the radiopharmaceutical instrumentation and has demonstrated leadership and operations skills of the caliber required for running AQCI as a CEO. He has built high-performance teams, launched new programs, achieved patent protection for multiple products, and has built productive relationships with partners, customers, vendors and regulators; accountable for multi-$MM budgets.

  • Default avatar
    Artem Lebedev

    Dr. Lebedev is well-known in the area of PET. During his career at Siemens, he has created a track record of consistently exceeding all expectationst. Artem’s scientific background uniquely combines radiochemistry, biology, chemistry, engineering, software development and analytical chemistry. Having all this knowledge at his disposal, Artem has been able to come up with the most elegant solutions to technical problems where others could not.